New Delhi: The Central Government is aiming to extend the per day variety of Covid-19 checks to 45 lakh by the tip of June, Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava stated on Thursday, including the goal is to is to do 25 lakh checks by the tip of this month.
Dr Bhargava stated the self-test dwelling kits will contribute to this course of, including one other three kits are more likely to get the nod quickly.
“For home testing for Covid-19, one company has already made the application and three are in the pipeline. Within a next week, we should have another three companies,” Dr Bhargava advised a media briefing right here.
“Step 1 is that you buy the test kit from a chemist. Step 2 – download mobile app. Step 3 – conduct the test at home. Step 4 – click mobile image and upload, test result will be given. Within three to four days, this should be available in the market,” he added.
The ICMR Director General stated labs are working around the clock to satisfy the elevated testing demand although the workforce of testing laboratories has been hit by the an infection.
Talking in regards to the steady improve within the variety of checks, Dr Bhargava stated if the case positivity charges of April and May are in contrast then there was a pointy fall because the weekly positivity charge of Covid-19 was 15 p.c between May 13 and May 19.
He, nevertheless, added the testing quantity will go up until the positivity charge comes down to 5 p.c.
The ICMR Director General additional stated extra of Rapid Antigen Tests needs to be completed as a result of you will get the outcomes quickly after which isolate the affected person rapidly.
Commenting on the medical doctors already prescribing 2-DG, developed by the Defence Research and Development Organisation (DRDO), for Covid remedy, Dr Bhargava stated: “DRDO’s 2-DG drug is a repurposed medicine, not a new medicine. It was earlier used for cancer treatment. Its trial results have been given to the DCGI.”
Earlier on Monday, the primary batch of anti-Covid drug 2-DG was launched by Union Defence Minister Rajnath Singh and Union Health and Family Welfare Minister Dr Harsh Vardhan.
Speaking on the launch, Dr Vardhan stated the drug would be the “first indigenous research-based outcome” to struggle the virus and can “reduce recovery time and oxygen dependency” within the nation.
This got here because the Drugs Controller General of India (DGCI) had earlier this month permitted the oral drug for emergency use as an adjunct remedy in average to extreme Covid-19 sufferers.
Meanwhile, Union Health Ministry Joint Secretary Lav Agarwal knowledgeable that eight states within the nation have multiple lakh lively instances, 9 states have between 50,000 to 1 lakh lively instances and 19 states have lower than 50,000 lively instances.
Check out under Health Tools-
Calculate Your Body Mass Index ( BMI )